Drug intelligence / Profile preview

prednisone + prednisolone

Development stage
Unknown
Lead developer
Bayer HealthCare Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Prednisone and prednisolone are synthetic glucocorticoid corticosteroids used for their potent anti-inflammatory, immunosuppressive, and lymphocytotoxic properties. Prednisone is a prodrug that is rapidly converted by the liver into its active metabolite, prednisolone. In oncology, they are frequently utilized as components of multi-agent chemotherapy regimens for hematologic malignancies, such as classical Hodgkin Lymphoma (cHL), where they exert direct lymphocytotoxic effects by inducing apoptosis in malignant lymphoid cells. Their mechanism involves binding to the cytosolic glucocorticoid receptor (GR), which then translocates to the nucleus to modulate the transcription of genes involved in inflammation, cell survival, and cytokine production.

Brand names
DeltasoneRayosMillipredOrapredPediapredPrelone
Other names
prednisoneprednisoloneglucocorticoids
02

Targets

GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)

Beyond the preview

Go deeper on prednisone + prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prednisone + prednisolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call